Donald Trump is now “in a race” against coronavirus according to the chief executive of the drug company who provided the experimental drug being taken by the president.
Dr Leonard Schleifer’s biotechnology company Regeneron have developed the experimental antibody treatment that was given to Mr Trump on Friday, before he was flown to hospital.
Mr Schleifer told CNN: “He’s in a race where his immune system is racing against the virus, and if the virus wins you can have dire consequences, obviously, and what our antibodies do is we make it a fair fight.”
“He’s in a higher risk group for a variety of reasons such as being older, and if we give our antibodies, we hope that we will give his immune system enough of a boost so that he can win this and make a complete recovery,” Dr Schleifer said.
“That’s the strategy. We’ve got a lot of data but we’re still in the experimental phase, but when you’re in the midst of a pandemic and you have people at risk, we think it makes sense to try these,” he added.